**Core Concept**
Fluoroquinolones are antibiotics that inhibit bacterial DNA gyrase and topoisomerase IV, disrupting DNA replication. *Mycobacterium leprae*, the causative agent of leprosy, is sensitive to certain fluoroquinolones, with **ofloxacin** being the most effective and preferred agent due to its optimal activity and clinical efficacy.

**Why the Correct Answer is Right**
Ofloxacin has the highest documented activity against *M. leprae* among fluoroquinolones, with a well-established role in multidrug therapy for leprosy. It achieves effective intracellular concentrations and demonstrates strong bactericidal effects against the slow-growing mycobacterium. The drug is specifically recommended in WHO guidelines for leprosy treatment due to its potency and favorable pharmacokinetics in mycobacterial infections.

**Why Each Wrong Option is Incorrect**
Option B: Pefloxacin is less effective against *M. leprae* and has limited clinical use in leprosy therapy; it is primarily used in other gram-negative infections.
Option C: Ciprofloxacin has some activity but is less effective than ofloxacin against *M. leprae* and has poor tissue penetration.
Option D: Moxifloxacin has broad-spectrum activity but is not the preferred agent for leprosy due to lower efficacy and higher risk of adverse effects in this context.

**Clinical Pearl / High-Yield Fact**
Ofloxacin remains the **first-line fluoroquinolone** for leprosy due to superior activity against *M. leprae* and proven efficacy in multidrug regimens — a key point in both Indian and WHO-recommended treatment protocols.

✓ Correct Answer: A. Ofloxacin